Lumora Ltd trading as Erba Molecular. Erba Molecular is an innovative molecular diagnostics company applying its commercially validated proprietary technology in sample preparation, amplification and detection to produce novel workflow based solutions to reduce the complexity of molecular testing. ERBA Molecular has successfully condensed complex molecular diagnostic technologies into a few simple steps requiring a minimally skilled operator and consequently the potential for a CLIA waivable POC system for use in a wide range of decentralized testing environments, including resource-poor settings in clinical diagnostics and industrial microbiology. ERBA Molecular has taken a workflow based approach to developing clinical mdx allowing non specialist users to perform testing. ERBA’s molecular diagnostic system is comprised of a next generation isothermal amplification technology that integrates innovative sample preparation technology with a patented, real-time detection technology that only requires a simple low cost reader. ERBA Molecular offers a turn-key solution to assay design and development for its commercial partners this includes bioinformatics analysis, amplification technology expertise and assay optimisation. This development process ensures the tests are as fast and robust as possible and are optimised for speed, quantitation or other required performance characteristics. At ERBA Molecular we consider molecular diagnostics to represent the full process from sample-to-result. Consequently we have developed multiple methods to prepare nucleic acids ready for amplification and detection. These can be incorporated with existing PCR approaches or combined with our technologies where we have developed a pathway to a CLIA waivable device. ERBA Molecular’s corporate office is based just outside of Cambridge, England.